Antidepressants ease fibromyalgia pain: study
LONDON (Reuters) - Antidepressants appear to relieve pain, sleep disturbances and other symptoms of fibromyalgia, a debilitating and painful ailment with no known cure, German researchers said on Tuesday.
A range of antidepressants look to improve quality of life for people with the condition that affects up to an estimated 6 percent of people in North America and Europe, they added.
“Fibromyalgia syndrome is also associated with high direct and indirect disease-related costs,” Winfried Hauser of Klinikum Saarbrucken in Germany and colleagues wrote in the Journal of the American Medical Association.
“Effective treatment of fibromyalgia syndrome is therefore necessary for medical and economic reasons.”
The condition mainly strikes women and can cause severe pain and tenderness in muscles, ligaments and tendons. Shoulder and neck pain is common but some people with the ailment also have problems sleeping, and suffer anxiety and depression.
Doctors usually prescribe exercise and relaxation techniques, painkillers or sometimes a low-dose antidepressant to treat the symptoms.
Pregabalin, a drug that calms nerve cells, gained U.S. regulatory approval last year to treat the condition. It is sold as Lyrica by Pfizer Inc.
Hauser and colleagues analyzed 18 previously published studies involving 1,427 participants and found strong evidence antidepressants led to improved symptoms and quality of life.
Older tricyclic and tetracyclic antidepressants seemed to have a large effect in easing pain, fatigue and sleep disturbances while selective serotonin reuptake inhibitors (SSRIs) such as Prozac had smaller effect for pain relief.
Prozac was initially introduced by U.S. drugmaker Eli Lilly and Co in 1987 and is now off patent and widely available generically as fluoxetine.
A newer class of treatments called serotonin and noradrenaline reuptake inhibitors (SNRIs) were linked to a reduction of pain, sleep disturbances and depressed mood, and monoamine oxidase inhibitors appeared to help reduce pain.
While the analysis suggests antidepressants may help, the researchers said doctors should closely monitor people using them because there is a lack of evidence about their long-term impact.
“Their effects should be re-evaluated at regular intervals to determine whether benefits outweigh adverse effects,” the researchers wrote.
(Reporting by Michael Kahn; editing by Tim Pearce)
--------------------------------------------------------------------------------------------Related Posts:
By Megan Rauscher NEW YORK (Reuters Health) - Depression and the chronic pain syndrome fibromyalgia are common in patients who suffer from chronic Lyme disease and seem to correlate with poor functional outcomes, results of a study indicate. The term chronic Lyme disease describes patients with persistent Lyme disease despite prior treatment with a conventional 2- to
Full Post: Depression, pain may accompany chronic Lyme disease
--------------------------------------------------------------------------------------------
By Julie Steenhuysen CHICAGO (Reuters) - The popular antidepressant Lexapro showed promise at easing anxiety symptoms in older adults, but the effect was “modest” and would need to be studied further, U.S. researchers said on Tuesday. They said antidepressants like Lexapro, made by Forest Laboratories Inc and known generically as escitalopram, may be useful as a new
Full Post: Lexapro may ease anxiety in older adults: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - French researchers have shown that patients with fibromyalgia have abnormal blood flow in the brain, which may be related to the underlying cause of the condition. “We found brain functional differences between patients with fibromyalgia and those who do not have the disorder,” lead investigator Dr. Eric Guedj told Reuters Health.
Full Post: Fibromyalgia patients show brain abnormalities
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - An insomnia drug that helps the body produce more of the sleep hormone melatonin may improve sleep for jet-lagged travelers and shift workers, researchers reported on Monday. Maryland-based Vanda Pharmaceuticals Inc. reported on two studies of its drug tasimelteon, also known as VEC-162, that showed it helped patients sleep longer and more deeply
Full Post: Insomnia drug helps jet-lag, shift-work troubles
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - The results of a study suggest that compression devices can produce significant improvements in patients with restless legs syndrome, a movement disorder that causes uncomfortable sensations in the legs that worsen when a person is inactive, such as during sleep. Drug therapy for restless legs syndrome (RLS) may be ineffective or
Full Post: Compression devices calm restless legs: study